Reader sentiment, not investment advice. One vote per visitor; click again to change it.
NMR last changed hands at $9.61 (down 1.79%). At $28.07B, Nomura Holdings is ranked #457 by size among the 800 stocks on BeStock.
Over a full year the shares have ranged across $6.58 to $10.94, which puts the current price roughly 69% of the way up that band.
For the quarter ended Jun 2026 it reported ¥612.38B in revenue, up 28.0% from a year earlier, with ¥156.12B of net profit (a 20.4% margin).
The stock changes hands at 11.3 times trailing earnings, 51% above its five-year average of 7.5. The median for its industry group is 27.0.
This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.
Composite of 3 factors below, ranked against the 800 U.S. stocks BeStock covers.
Cheaper than usual on its own 5-year P/E history scores higher.
Higher trailing yield than most of BeStock’s coverage scores higher.
Trading closer to its 52-week high than most peers scores higher.
How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.
NMR is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.
Since 2020-07-06, the strategy has returned 1524.8% (321.7% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated weekly — not a guarantee of future results, and not a BeStock recommendation.
What Wall Street analysts and Morningstar's fair-value model expect for the stock
Morningstar’s fair value model puts the stock at $9.57, so shares trade 0.3% above that estimate. On earnings multiple, it sits in the 45th percentile of its own five-year valuation range (cheaper than usual).
Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.
Quote as of Oct 1, 2026 11:50 am ET. Prices can lag the live tape. This is background information, not a recommendation.
Ranks are among the 800 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.
Set against the peer table: at 11.3x earnings, NMR looks cheap against the market, and trades 58% below the 27.0x median among Capital Markets names. The two comparisons do not always agree.
$9.61 is the latest print for NMR, a move of -1.79% against yesterday's close of $9.78. Today's low and high so far: $9.55 and $9.80.
Equity value comes to $28.07B at the current price. By that measure it is number 457 of the 800 names in our coverage.
Buyers pay 11.3 times the last twelve months of profit (EPS $0.76). Averaged over five years the multiple has been 7.5, and today's level ranks in the 45th percentile of its own history.
The year's floor is $6.58 and the ceiling $10.94. Shares are 12.2% away from that ceiling.
It does. Payouts over the past twelve months work out to a 3.20% yield; the latest ex-dividend date was March 31, 2026.
BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.
No comments yet — be the first to weigh in on NMR.